A critical breakthrough in cancer investigation is arising with the use of mini-antibodies to re-engage mutated p53. This essential malignant inhibitor protein is frequently inactivated in many types of cancer, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research